awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48192887-E86E75AE-0AB8-4C67-ADA3-331B00E82561
Q48192887-E86E75AE-0AB8-4C67-ADA3-331B00E82561
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48192887-E86E75AE-0AB8-4C67-ADA3-331B00E82561
Emerging role of immunotherapy in precursor B-cell acute lymphoblastic leukemia.
P2860
Q48192887-E86E75AE-0AB8-4C67-ADA3-331B00E82561
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48192887-E86E75AE-0AB8-4C67-ADA3-331B00E82561
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b3d545dd9f1e1d8113265e6b2e0a1b4e41e97e36
P2860
(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study.